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MASTL promotes cell contractility and motility
through kinase-independent signaling
Maria Emilia Taskinen1*, Elisa Närvä1*, James R.W. Conway1, Laura Soto Hinojosa2, Sergio Lilla3, Anja Mai1, Nicola De Franceschi1, Laura L. Elo1,
Robert Grosse2, Sara Zanivan3,4, Jim C. Norman3,4, and Johanna Ivaska1,5
Microtubule-associated serine/threonine-protein kinase-like (MASTL) is a mitosis-accelerating kinase with emerging roles in
cancer progression. However, possible cell cycle–independent mechanisms behind its oncogenicity remain ambiguous. Here, we
identify MASTL as an activator of cell contractility and MRTF-A/SRF (myocardin-related transcription factor A/serum
response factor) signaling. Depletion of MASTL increased cell spreading while reducing contractile actin stress fibers in
normal and breast cancer cells and strongly impairing breast cancer cell motility and invasion. Transcriptome and proteome
profiling revealed MASTL-regulated genes implicated in cell movement and actomyosin contraction, including Rho guanine
nucleotide exchange factor 2 (GEF-H1, ARHGEF2) and MRTF-A target genes tropomyosin 4.2 (TPM4), vinculin (VCL), and
nonmuscle myosin IIB (NM-2B,MYH10). Mechanistically, MASTL associated with MRTF-A and increased its nuclear retention and
transcriptional activity. Importantly, MASTL kinase activity was not required for regulation of cell spreading or MRTF-A/SRF
transcriptional activity. Taken together, we present a previously unknown kinase-independent role for MASTL as a regulator
of cell adhesion, contractility, and MRTF-A/SRF activity.
Introduction
Microtubule-associated serine/threonine-protein kinase-like
(MASTL, also known as Greatwall kinase) has emerged as a
putative oncogene that is highly expressed in several cancers
(Marzec and Burgess, 2018). In breast cancer, MASTL expres-
sion increases with advanced clinical stage and predicts poor
survival (Álvarez-Fernández et al., 2018; Rogers et al., 2018;
Wang et al., 2016; Yoon et al., 2018), with high MASTL levels
positively correlating with increased tumor growth and me-
tastasis in vivo (Álvarez-Fernández et al., 2018; Rogers et al.,
2018; Vera et al., 2015). Moreover, knockdown of MASTL
induces radiosensitivity (Nagel et al., 2015), which makes
MASTL an appealing pharmacological target. However, the
exact mechanism of how MASTL facilitates tumorigenicity
remains unknown. Interestingly, while kinase inhibitors of
MASTL are under development as potential drugs for cancer
therapy (Ammarah et al., 2018), the role of MASTL kinase
activity remains unclear in relation to its oncogenic
properties.
Cell adhesion plays a critical role in cancer progression and
metastasis (Hamidi and Ivaska, 2018), where serine/threonine
kinases are important regulators of adhesion and contraction
(Zaidel-Bar et al., 2015). MASTL has an established role in the
acceleration of cell cycle progression through phosphorylation of
Endosulfine Alpha (ENSA) and Arpp19, which inhibit PP2A-B55
phosphatase activity and thus maintain the phosphorylation of
CDK1 substrates (Vigneron et al., 2016). However, recent studies
suggest that MASTL has additional roles besides cell cycle reg-
ulation, such as during DNA replication (Charrasse et al., 2017),
recovery from DNA damage (Wong et al., 2016), and regulation
of epithelial cell contact inhibition (Rogers et al., 2018). Here, we
demonstrate a kinase-activity independent role for MASTL in
governing/restraining cell spreading and attachment to the ECM
in mammary epithelial and breast cancer cells. Mechanistically,
MASTL regulates serum response factor (SRF)/myocardin-re-
lated transcription factor (MRTF)–mediated transcription in a
kinase-independent manner through associating with MRTF-A
and supporting its nuclear retention. MASTL induces cell con-
tractility and cell migration by supporting the expression of
several proteins, including Rho guanine nucleotide exchange
factor 2 (GEF-H1) and the SRF/MRTF target genes tropomyosin
4.2 (Tpm4.2), nonmuscle myosin IIB (NM-2B), and vinculin
(VCL).
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Results
MASTL inhibits cell spreading and attachment
To investigate whether MASTL would play a role in cell adhe-
sion, we silenced MASTL for 48 h in MDA-MB-231 breast cancer
cells and imaged cell morphology following replating on collagen
for 2 h. MASTL-depleted cells were significantly more spread
than the control siRNA transfected cells (Fig. 1, A and B; and
statistics for all experiments, Table S1). Furthermore, MASTL
silencing significantly increased cell attachment (area occupied
by cells on ECM) of single cells plated andmonitored in real time
(Fig. 1 C). Increased cell attachment after MASTL silencing was
observed with two independent siRNA oligos and was similar on
collagen and fibronectin (Fig. S1, A–D).
Conversely, EGFP-MASTL WT overexpression significant-
ly reduced cell spreading compared with the EGFP control
(Fig. 1, D and E; and Fig. S1 E). Expressing siRNA-resistant WT
EGFP-MASTL fully reversed the increased cell spreading in
MASTL-silenced breast cancer cells (Fig. 1, F–I; and Fig. S1 F).
Interestingly, expression of kinase-dead MASTL (EGFP-MASTL
G44S; Vera et al., 2015) was equally effective in reversing
spreading of MASTL-silenced MDA-MB-231 cells (Fig. 1, G and
H), indicating that MASTL regulates cell spreading independent
of its kinase activity.
MASTL was expressed in normal human mammary epithelial
MCF10A, luminal breast cancer MCF7, and triple-negative breast
cancer MDA-MB-231 cells, with the highest expression detected in
the cancer cells (Fig. S2 A). Importantly,MASTL depletion increased
significantly the spreading of MCF10A (Fig. 2, A and B) and MCF7
cells (Fig. S2, B and C), indicating that this effect is not restricted to
MDA-MB-231 cancer cells. Taken together, these data suggest that
MASTL inhibits cell spreading and adhesion in normal and can-
cerous mammary epithelial cells on different ECM substrates.
MASTL regulates cell spreading independently of focal
adhesion size, integrin activity, or cell cycle
To investigate the possible mechanisms of MASTL-induced in-
hibition of cell spreading, we studied if MASTL silencing affects
focal adhesions or integrin expression/activity. MASTL silenc-
ing did not significantly influence the size of paxillin-positive
focal adhesions between control and silenced cells (Fig. 2 C).
However, while the significantly more spread MASTL-silenced
cells displayed a larger number of focal adhesions per cell, this
equated to fewer adhesions over cell area when compared with
the smaller control cells (Fig. 2 D). Silencing of MASTL increased
slightly, but significantly, the levels of total β1 integrin at the cell
surface (Figs. 2 E and S2 D) in MDA-MB-231 cells. However, the
levels of active β1 integrin (detected with the conformation
specific 12G10 antibody) and overall β1 integrin activity (relative
activation index) were not changed (Fig. 2, F and G; and Fig. S2,
E–G). In addition, binding of MASTL-silenced cells to labeled
fibronectin (FN7-10 fragment) was slightly but significantly
lower than in control cells (Fig. 2 H). Thus, MASTL does not
inhibit cell spreading through the regulation of integrin-ECM
affinity or focal adhesion size.
Long-term silencing of MASTL has been reported to cause a
delay in the G2 phase of the cell cycle (Voets and Wolthuis,
2010), whereas short-term silencing (48 h) has no effect on
the cell cycle of human dermal fibroblasts, human umbilical vein
endothelial cells, or MCF10A cells (Yoon et al., 2018). Similarly,
we found that the cell cycle profile of MDA-MB-231 cells was
unaltered after short-term (48 h, used in all of our experiments)
MASTL silencing (Fig. 2 I; and Fig. S2, H and I).
Previouswork has demonstrated thatMASTL-overexpressing
MCF10A cells fail to form a single monolayer, with cells dis-
playing disorganized actin, E-cadherin, and β-catenin localiza-
tion (Rogers et al., 2018). We found that MASTL silencing, in
confluent MCF10A cells, dramatically increases cell spreading
without disrupting E-cadherin or β-catenin localization to
junctions or significantly affecting junction alignment (Fig. 3,
A–F). However, junctions were occasionally disrupted, leaving
gaps in the MASTL-silenced cell monolayer (Fig. 3, A and B).
MASTL supports expression of cell movement– and actin
cytoskeleton–related genes
To obtain an unbiased view of the molecular players implicated
in MASTL control of cell adhesion, we performed genome-wide
transcriptome analysis inMASTL-depleted cellsFig. S3, A and B).
Genes with a false discovery rate (FDR) <5% were considered as
differentially expressed; this resulted in 139 and 247 altered
transcripts at 24 h and 48 h after MASTL silencing, respectively
(Fig. 4 A and Table S2). The changes at 24 h and 48 h were highly
correlated (Pearson correlation 0.73, P < 2.2e-16). Interestingly,
nearly 75% of all the differentially expressed transcripts were
down-regulated after MASTL silencing, implying that MASTL
supports mRNA levels of multiple genes. Ingenuity Pathway
Analysis software (Qiagen; https://www.qiagenbioinformatics.
com/products/ingenuitypathway-analysis) revealed that the
major function suppressed in MASTL-depleted cells was mi-
gration and invasion (Fig. 4 B).
Next, we investigated the effect of MASTL depletion on the
cellular proteome using quantitative SILAC (stable isotope la-
beling with amino acids in cell culture)–based mass spectrom-
etry proteomics (Fig. S3 C). Out of 8,418 identified proteins, 52
were found to be significantly altered in all four replicates (Fig. 4
C and Table S3). In line with the transcriptome analysis, the
majority of the altered proteins were down-regulated. In addi-
tion, the top function identified was cellular movement (P =
3.24E-07). Furthermore, more than half of the down-regulated
proteins overlapped with the down-regulated mRNAs (Fig. 4 D).
This suggests that MASTL regulates cell morphology via control
of cell movement–related genes.
MASTL induces GEF-H1, TPM4.2, and NM-2B levels
To identify possible actin regulators that may control MASTL-
dependent cell spreading and cellular movement, we compared
the transcriptome and proteome of MASTL-silenced cells to the
contractome, a list of 100 literature-curated proteins associated
with actomyosin contraction in nonmuscle cells (Zaidel-Bar
et al., 2015; Fig. 5 A). This analysis highlighted the potential
role of Rho guanine nucleotide exchange factor 2 (GEF-H1,
ARHGEF2) as a contractility regulator downstream of MASTL.
GEF-H1 is one of the key regulators of actomyosin contraction
and cell motility. It induces F-actin meshwork formation in la-
mellipodia and membrane ruffles and facilitates cell retraction
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Figure 1. MASTL inhibits cell spreading and attachment through kinase-independent functions. (A) Representative images of F-actin (Phalloidin-Atto)
and DAPI staining in control (siControl) or MASTL-silenced (siMASTL; 48-h silencing) MDA-MB-231 cells plated on collagen for 2 h. Images were acquired on a
Zeiss LSM 880 Airyscan confocal. (B) Quantification of cell area based on F-actin staining of 45 cells (three independent experiments) from A. (C) Real-time
monitoring of siControl or siMASTL cell area (normalized cell index) during cell spreading measured with the xCELLigence RTCA system. Single-cell suspensions
were plated on collagen. BSA coating was used as a negative control. Shown are representative curves from an individual experiment. (D) Representative
F-actin (Phalloidin-Atto) and DAPI staining in EGFP-control and EGFP-MASTL WT–overexpressing (24 h) MDA-MB-231 cells plated on collagen for 2 h. Images
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by enhancing actin stress fiber formation (Birkenfeld et al.,
2008). In addition, other contractome proteins including tro-
pomyosin 4.2 (Tpm4.2, TPM4), an actin-binding protein that
supports stress fiber formation and actomyosin contraction
through nonmuscle myosin II ATPase activity (Gateva et al.,
2017; Geeves et al., 2015; Tojkander et al., 2011), and NM-2B
(MYH10), a nonmuscle myosin-2 isoform, were significantly
down-regulated in MASTL-silenced cells.
We validated the down-regulation of ARHGEF2 (GEF-H1), TPM4
(Tpm4.2), and MYH10 (NM-2B) in MASTL-silenced MDA-MB-231
cells using real-time quantitative PCR (RT-qPCR) analysis (Fig. 5 B),
Western blot (Fig. 5, C–H; and Fig. S4 A) and immunofluorescence
(Fig. S4 B). GEF-H1 was clearly reduced in MDA-MB-231 cells si-
lenced with two independent siRNA oligos (Fig. 5 C; and Fig. S4, A
and B) and in MCF10A cells (Fig. S4 C), suggesting that regulation
of GEF-H1 is not restricted to cancer cells. Unfortunately, we were
unable to detect NM-2B or Tpm4.2 in MCF10A cells consistently
due to the lack of specific bands in the Western blot. However, we
were able to validate Tpm4.2 reduction in MASTL-silenced con-
fluent MCF10A cells with two independent siRNAs using immu-
nofluorescence (Fig. S4 D). Importantly, down-regulation of GEF-
H1, Tpm4.2, andNM-2Bwas reversed upon reexpression of siRNA-
resistant EGFP-MASTL in MDA-MB-231 cells (Fig. 5 I), indicating
that the down-regulation of these proteins was not due to any
were acquired on a 3i CSU-W1 spinning disk confocal. (E) Quantification of cell area based on the F-actin staining of 45 cells (three independent experiments)
from D. (F)Western blot analysis of MASTL levels in siControl, siMASTL, and siMASTL + EGFP-MASTL WT (24 h MASTL silencing + 24 h expression of siRNA-
resistant EGFP-MASTLWT) MDA-MB-231 cells. Tubulin was used as a loading control. (G) Representative images of F-actin (Phalloidin-Atto) and DAPI staining
in siControl, siMASTL, siMASTL + EGFP-MASTL WT, or siMASTL + EGFP-MASTL G44S MDA-MB-231 cells plated on collagen for 2 h (3i CSU-W1 spinning disk
confocal). (H) Quantification of cell area based on the F-actin staining of 45 cells (three independent experiments) from G. (I) Representative cell spreading
curves and cell area (normalized cell index; as in C) of siControl, siMASTL, or siMASTL + EGFP-MASTL WTMDA-MB-231 cells. Data in all graphs are from n = 3
biologically independent experiments (unpaired t test, mean ± SD). See also Fig. S1 and Table S1.
Figure 2. MASTL regulates cell spreading independently of focal adhesion size, integrin activity, or cell cycle. (A) Representative images of F-actin
(Phalloidin-Atto), paxillin, and DAPI staining in siControl and siMASTL (48 h silencing) MCF10A cells plated on collagen for 2 h. Images were acquired on a 3i
CSU-W1 spinning disk confocal. (B–D) Quantification of cell area based on F-actin staining, 45 cells/condition in total (B), focal adhesion size based on paxillin
staining (C), and focal adhesion count based on paxillin relative to individual cells or total cell area (D), with 47 (siControl) or 44 (siMASTL) cells in total (three
independent experiments) from A. (E and F) Representative flow cytometry histograms of total β1-integrin (P5D2; E) or active β1-integrin (12G10; F) in si-
Control and siMASTL MDA-MB-231 cells. (G) Quantification of active β1 integrin (12G10) levels relative to total β1 integrin (P5D2) from E and F. (H) Quan-
tification of integrin binding to labeled fibronectin (FN-647) relative to total β1 integrin (P5D2) analyzed with flow cytometry. (I) Cell cycle profiles of siControl
and siMASTL MDA-MB-231 cells. Data in all graphs are from n = 3 biologically independent experiments (unpaired t test, mean ± SD). See also Fig. S2 and Table
S1.
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Figure 3. MASTL regulates cell spreading, but not junctional orientation, of confluent MCF10A cells. (A and B) Representative images of E-cadherin,
β-catenin, F-actin (Phalloidin-Atto), and DAPI staining, and orthogonal view of the monolayer in siControl and siMASTL (48 h silencing) confluent MCF10A
cultures. Images were acquired on a 3i CSU-W1 spinning disk confocal. (C) Quantification of cell area in a monolayer based on β-catenin staining (three
independent experiments, with 251 [siControl], 133 [siMASTL#6], or 189 [siMASTL#11] cells in total). (D) Quantification of relative height of monolayer based
on β-catenin staining (three independent experiments, 11 [siControl], 13 [siMASTL#6], or 13 [siMASTL#11] images in total). (E) Representative images of the
local orientation of β-catenin–stained junctions represented by the corresponding color assigned to each specific angle of orientation, from −90° to 90°.
(F) Analysis of cell–cell junction orientation in control and MASTL-silenced cells according to β-catenin staining using the OrientationJ ImageJ plugin (see
Materials and methods). Frequency distributions of relative junctional orientations were then averaged over 12 images per condition, and the frequency of
junction alignment was calculated across the ±30° spanning the peak. See also Table S1.
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off-target effects of RNAi. Expression of EGFP-GEF-H1 in MASTL-
depleted MDA-MB-231 cells significantly reduced spreading of
MASTL-silenced cells (Fig. 5, J and K; and Fig. S4 E), indicating that
GEF-H1–mediated contractility can overcome the effect of MASTL
depletion on cell spreading.
High MASTL levels promote contractile actin stress fibers
Next, we studied how MASTL affects the actin cytoskeleton and
phosphorylation of the myosin light chain (MLC), a key regu-
lator of actomyosin contraction (Murrell et al., 2015). We plated
MDA-MB-231 cells on collagen-coated crossbow-shaped micro-
patterns to normalize cell shape and facilitate comparisons be-
tween control and MASTL-silenced cells. In control cells, there
were notable phosphorylated MLC (pMLC)–positive actin stress
fibers across the cell. In contrast, a large proportion of MASTL-
depleted cells displayed a reduced number of actin stress fibers
and the accumulation of actin at the cell edge, resulting in
broader lamellipodial actin structures (Fig. 6, A–C). In addition,
and in line with immunofluorescence images, total pMLC levels
were lower in MASTL-depleted cells (Fig. 6, D and E), and levels
were restored by reexpression of siRNA-resistant EGFP-MASTL
(Fig. 6 F). These results imply that silencing of MASTL decreases
stress fiber formation and actomyosin contraction.
MASTL supports cell migration
Actin dynamics and actomyosin contraction play central roles in
cell migration (Pollard and Cooper, 2009; Rottner et al., 2017). As
MASTL depletion affected key regulators of actomyosin contrac-
tion and contractile actin fibers, we studied the migration prop-
erties of the cells using live-cell imaging (Fig. 7 A and Videos 1 and
2). Control-silenced cells moved rapidly with a prominent leading
edge. In contrast, MASTL-silenced cells were round, flat, and sta-
tionary with significantly reduced cell migration distance (Fig. 7, B
and C; and Fig. S4 F validation with a second siRNA oligo). Similar
flat morphology has been detected in MASTL-silenced thyroid
cancer cells recently (Cetti et al., 2019). This was not due toMASTL
regulation of focal adhesion dynamics. Live-cell imaging of
mEmerald-paxillin–labeled control and MASTL-silenced cells
showed no significant differences in focal adhesion assembly or
disassembly kinetics (Fig. 7 D–G; and Video 3). Accordingly,
MASTL silencing had no effect on paxillin phosphorylation, an
established regulator of focal adhesion turnover (Zaidel-Bar et al.,
2007; Fig. 7, H and I). Importantly, increasing cell contractility
through overexpression of GEF-H1 was not sufficient to rescue
migration ofMASTL-silenced cells (Fig. S4 F). These results suggest
that MASTL depletion, leading to reduced levels of key cellular
movement regulators, triggers defective cell migration.
Figure 4. MASTL supports expression of cell movement– and actin cytoskeleton–related genes. (A) Venn diagram of differentially expressed transcripts
(FDR < 0.05) measured with Illumina HT-12 at 24 h and 48 h after MASTL silencing in MDA-MB-231 cells. (B) Migration- and invasion-associated transcripts
affected at RNA level after MASTL silencing according to Ingenuity Pathway Analysis. (C) A density scatterplot of SILAC proteome data displaying log2 of
median protein ratios (siMASTL compared with siControl MDA-MB-231 cells) and total protein intensity. Each dot represents a protein. The color scale of the
data point density is indicated on the right. Highlighted black circles represent significantly regulated proteins according to the significance B test. (D) List of
differentially regulated hits identified in both the transcriptome and the total proteome datasets (shared identification). Blue, down-regulated hits; red, up-
regulated hits. See also Fig. S3 and Table S2 and Table S3.
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Figure 5. MASTL induces GEF-H1, Tpm4.2, and NM-2B levels. (A) Comparison of the transcriptome and proteome of MASTL-silenced MDA-MB-231 cells
with known contractome-associated factors (Zaidel-Bar et al., 2015). (B) Quantification of relative mRNA levels of MASTL, ARHGEF2, TPM4 and MYH10 after
MASTL silencing (48 h) in MDA-MB-231 cells based on real-time PCR analysis. (C-H)Western blot analysis and quantifications of GEF-H1, Tpm4.2, NM-2B, and
MASTL protein levels in siControl and siMASTL MDA-MB-231 cells. Protein levels are normalized to GAPDH. (I) Western blot analysis of NM-2B, GEF-H1, and
Tpm4.2 protein levels in siControl, siMASTL, or siMASTL + EGFP-MASTL (24 h MASTL silencing + 24 h expression of siRNA-resistant EGFP-MASTL) MDA-MB-
231 cells. Mean protein levels quantified from three independent experiments relative to GAPDH are shown above indicated blots. (J) Representative F-actin
(Phalloidin-Atto) and DAPI staining in siMASTL MDA-MB-231 cells transfected with EGFP-GEF-H1 for 24 h and plated on collagen for 2 h. Images were acquired
on a 3i CSU-W1 spinning disk confocal. (K) Quantification of cell area based on the F-actin staining of 45 cells/condition in total (three independent ex-
periments) from J. Data in all graphs are from three (B, F, and H) or four (D) biologically independent experiments (unpaired t test, mean ± SD). See also Table S1
and Fig. S4.
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MASTL regulates SRF activity kinase activity independently
SRF and MRTF-A are key regulators of cell motility as they
jointly regulate transcription of genes related to actin dynamics,
cell adhesion, and actomyosin contraction (Gau and Roy, 2018;
Olson and Nordheim, 2010). As Tpm4.2 is a known target of SRF
(Esnault et al., 2014) and GEF-H1 has been shown to induce SRF
(Itoh et al., 2014), we decided to investigate the influence of
MASTL on SRF activity. In MCF10A cells, MASTL depletion
down-regulatedmRNA levels of the established SRF target genes
VCL (vinculin) and FOS (Fig. 8 A). Total protein levels of vinculin
were also significantly decreased, while levels of paxillin, which
is not an SRF target gene, remained unchanged following
MASTL depletion (Fig. 8, B and C; and Fig. S5 A). Accordingly,
there was less vinculin in focal adhesions of MASTL-silenced
MCF10A cells (Fig. S5 B). Even though vinculin levels were
lower in MASTL-silenced (two independent siRNA oligos)
MCF10A cells, vinculin was still observed at cell–cell junctions
(Fig. S5 C). Importantly, MASTL silencing, in MCF10A cells
stably expressing the MRTF-SRF luciferase reporter, blocked
serum-induced SRF transcriptional activity to a similar extent
than SRF silencing with a validated specific siRNA (Hinojosa
et al., 2017; Fig. 8 D). Conversely, overexpression of WT and
kinase-dead MASTL augmented serum-induced SRF transcrip-
tional activity (Fig. 8 E). These results indicate that MASTL
expression, but not kinase function, is required for SRF activity
and expression of SRF target genes.
Recently, a mutation (E167D) in MASTL has been linked to
thrombocytopenia and cytoskeletal defects in platelets, indica-
tive of a loss-of-function mutation (Hurtado et al., 2018). We
generated the corresponding mutant (EGFP-MASTL-E167D) and
found that it had no significant effect on SRF activity when
overexpressed in cells expressing endogenous MASTL (Fig.
S5 D), implying that E167D mutant MASTL is unable to induce
SRF activity.
Figure 6. High MASTL levels promote contractile actin stress fibers. (A) Representative images of F-actin (Phalloidin-Atto) and pMLC (Thr18/Ser19)
staining in siControl and siMASTL MDA-MB-231 cells plated on collagen-coated crossbow-shaped micropatterns (37 µm). (B) Quantification of the number of
actin stress fibers in A (low, no obvious stress fibers; moderate, one to four stress fibers; high, five or more stress fibers). (C) Analysis of lamellipodium width
from A, 38 (siControl) or 59 (siMASTL) cells in total. The width of the lamellipodiumwas measured from the widest point of the lamellipodium, 38 (siControl) or
60 (siMASTL) cells in total (narrow, 0–1.2 µm; moderate, 1.2–2 µm; and wide, >2 µm; n = 3 biologically independent experiments, Fisher’s exact test).
(D) Western blot analysis of phosphorylated (Ser20) and total MLC (pMLC and MLC, respectively) and MASTL protein levels in siControl and siMASTL MDA-
MB-231 cells. GAPDH was used as a loading control. (E) Quantification of pMLC relative to total MLC protein levels after MASTL silencing (n = 3 biologically
independent experiments, unpaired t test, mean ± SD). (F)Western blot analysis of pMLC (Ser20) and total MLC, MASTL and GAPDH protein levels in siControl,
siMASTL, and siMASTL + EGFP-MASTL (24 h MASTL silencing + 24 h expression of siRNA-resistant EGFP-MASTL) MDA-MB-231 cells. Shown is a repre-
sentative blot of three biologically independent experiments with similar results. See also Table S1.
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Figure 7. MASTL supports cell migration without influencing focal adhesion dynamics. (A) Representative phase contrast images from a 90-min time-
lapse movie of siControl and siMASTL MDA-MB-231 cells (Nikon Eclipse Ti-E widefield microscope, Hamamatsu Orca C13440 Flash 4.0 ERG [b/w] sCMOS
camera and Plan Apo lambda 20×/0.80, WD 1,000-µm objective). (B) Migration maps based on X and Y coordinates of siControl and siMASTL cells, recorded
every 10 min, 700 min in total (9 tracks per condition shown with different colors; Nikon Eclipse Ti-E widefield microscope). (C) Migration track length of
siControl and siMASTL cells (45 cells/condition in total, n = 3 biologically independent experiments, mean ± SD, unpaired t test with Welch’s correction).
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MRTF-A binds G-actin, and signal-regulated changes in cel-
lular G-actin concentration control the nuclear translocation of
this complex. However, depletion of MASTL had no effect on
F-actin/G-actin ratio in MCF10A cells under normal growth
conditions, whereas the actin filament polymerizing and stabi-
lizing drug jasplakinolide significantly increased the ratio,
serving as a positive control for the assay (Fig. S5, E and F).
MASTL associates with MRTF-A and regulates nuclear
retention of MRTF-A
SRF and MRTF-A coregulate cytoskeletal genes following nu-
clear translocation ofMRTF-A from the cytoplasm to the nucleus
(Miralles et al., 2003). In line with the significantly reduced SRF
activity in MASTL-depleted cells, we observed that MASTL de-
pletion clearly attenuates serum-induced nuclear translocation
of MRTF-A compared with control cells (Fig. 9 A). Conversely,
overexpression of WT and kinase-dead MASTL augmented nu-
clear MRTF-A localization in response to serum (Fig. 9 B). In-
terestingly, the MASTL E167D patient mutant was unable to
accelerate nuclear location of MRTF-A (Fig. 9 B), in line with its
inability to augment SRF activity. These data suggest that
MASTL is required for efficient signal-regulated nuclear trans-
location of MRTF-A and SRF activation independently of an ef-
fect on the F-actin/G-actin ratio.
In line with earlier publications, we find that MASTL is
predominantly nuclear (Fig. 1, D and G). This prompted us to
investigate whether MASTL associates with MRTF-A. Endoge-
nous MRTF-A was readily detected from GFP pull-downs of
EGFP-MASTL WT and EGFP-MASTLG44S, but not GFP alone, in
MCF7 cells (Fig. 9 C). Finally, fluorescence loss in photobleaching
(FLIP) analysis of MRTF-A nuclear retention through repeated
bleaching of the cytoplasmic MRTF-A pool revealed that MASTL
(D–G) Quantitative image analysis of focal adhesion dynamics based on live-cell imaging of endogenously tagged mEmerald-Paxillin in MDA-MB-231 cells.
Visualization of the entire set of focal adhesions recorded every minute for a total of 40 min (D). Quantification of focal adhesion lifetime (E), focal adhesion
assembly rate (F), and focal adhesion disassembly rate (G). Total number of cells/condition is indicated in the figure and Table S1. (H) Western blot analysis of
MASTL, phospho-paxillin (Tyr118), and paxillin levels in siControl and siMASTL (48 h silencing) MDA-MB-231 cells. GAPDH used as a loading control. (I) Quan-
tification of phospho-paxillin relative to paxillin after MASTL silencing (n = 3 biologically independent experiments, unpaired t test, mean ± SD). See also Table S1.
Figure 8. MASTL regulates SRF activity independent of its kinase activity. (A) Quantification of SRF, VCL, and FOS mRNA levels relative to TATA-box
binding protein (TBP) in siMASTL (72 h silencing) MCF10A cells (n = 2 biologically independent experiments, mean ± SD). (B)Western blot analysis of vinculin,
paxillin, and MASTL protein levels in siControl and siMASTL MCF10A cells after 48 h of silencing. GAPDH was used as a loading control. (C) Quantification of
vinculin levels in B after MASTL silencing. Protein levels are normalized to GAPDH (n = 3 individual experiments). (D) Relative SRF luciferase activity in si-
Control, siMASTL and siSRF (SRF-silenced) MCF10A cells following 48 h of silencing under serum-starved conditions and after stimulation with 20% serum (n = 3
individual experiments). (E) Relative SRF luciferase activity. MCF7 cells expressed EGFP control, EGFP-MASTL WT, and EGFP-MASTL G44S together with the
SRF reporter 3D.Aluc and RLTK Renilla luciferase transfection control under serum-starved conditions and after stimulation with 20% serum (n = 4 individual
experiments). Unpaired t test and mean ± SD is used in all graphs. See also Table S1.
Taskinen et al. Journal of Cell Biology 10 of 23
MASTL: A transcriptional regulator of cytoskeleton https://doi.org/10.1083/jcb.201906204
D
ow
nloaded from
 https://rupress.org/jcb/article-pdf/219/6/e201906204/1042522/jcb_201906204.pdf by guest on 05 M
ay 2020
silencing significantly enhances loss of nuclear GFP-MRTF-A
signal compared with control cells (Fig. 9, D–F). Taken together,
these data indicate that MASTL associates with MRTF-A and
supports nuclear retention of MRTF-A in cells.
Silencing of MASTL inhibits cancer cell invasion and regulates
cell morphology in 3D
Our data demonstrate MASTL as a key regulator of MRTF-A
localization and activity. Nextwe compared the effects ofMRTF-A
Figure 9. MASTL associateswithMRTF-A and regulates nuclear retention ofMRTF-A. (A) Live-cell imaging of siControl and siMASTLMCF10A cells stably
expressing pIND20-MRTF-A-GFP. Cells were serum starved (24 h) before imaging and MRTF-A-GFP translocation was followed after adding 20% serum (LSM
800 confocal microscope; Zeiss). Analysis of MRTF-A nuclear intensity in siControl and siMASTL cells 0, 120, 240, and 600 s after serum stimulation based on
live-cell imaging of 8–9 cells/condition is shown (n = 3 independent experiments). (B) Nuclear/cytoplasmic ratio of MRTF-A in EGFP control, EGFP-MASTLWT,
EGFP-MASTL G44S, and EGFP MASTL E167D–overexpressing MCF7 cells fixed 0, 2, or 5 min after adding serum and stained for MRTF-A (n = 3 independent
experiments). (C) Western blot of MRTF-A and MASTL in GFP immunoprecipitations and original lysate in EGFP control, EGFP-MASTL WT, and EGFP-MASTL
G44S–overexpressing MCF7 cells (n = 3 independent experiments). (D-F) FLIP representative images (D) and analysis (E and F) of MRTF-A nuclear trans-
location through repeated bleaching of the cytoplasmic MRTF-A-GFP pool in siControl and siMASTL MCF7 cells after 10 min of serum stimulation. Repre-
sentative fluorescence intensity curves from two individual cells (E) and quantification of rate of decay (F) are shown (n = 3 biological replicates, with 13 cells in
total/condition). See also Table S1.
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and MASTL silencing. Silencing of MRTF-A induced cell spread-
ing (Fig. 10, A and B) and decreased the expression of vinculin, an
established SRF target gene (Miralles et al., 2003), but not paxillin
(Fig. 10 C), similarly to MASTL silencing (Figs. 2 A and 8 B). GEF-
H1 levels were not decreased by MRTF-A silencing, in line with
the notion that GEF-H1 is not an SRF target gene (Itoh et al., 2014;
Ly et al., 2013). These results indicate that MRTF-A activation
downstream of MASTL is a key regulatory step in cell spreading.
To investigate this further, we analyzed cell invasion in three-
dimensional extracellular matrix. Depletion of MRTFs or SRF is
known to reduce MDA-MB-231 cell invasion (Medjkane et al.,
2009). We found that silencing of MASTL significantly inhibits
MDA-MB-231 invasion into a fibronectin-supplemented collagen I
gel, similar to MRTF-A silencing (Fig. 10, D and E). In addition,
MASTL- or MRTF-A–silenced cells were rounder than the elon-
gated control cells (Fig. 10, F and G). Importantly, MASTL si-
lencing reduced nuclear localization of endogenous MRTF-A in
cells in 3D (Fig. 10, H and I), suggesting that MASTL is required
for MRTF-A–regulated cancer cell invasion in 3D.
Discussion
We describe here an original kinase-independent function for
the well-recognized mitosis accelerator, MASTL, in regulating
cell morphology. Our data establish an intimate link between the
predominantly nuclear MASTL and regulation of cell adhesion,
cell contractility, spreading, and motility. We demonstrate that
MASTL localizes to the nucleus, associates with MRTF-A and is
necessary for the full activity of the MRTF/SRF signaling path-
way, a key coordinator of gene transcription and cytoskeletal
dynamics (Esnault et al., 2014). MASTL regulates a transcrip-
tional contractility/adhesion program in normal epithelial cells
and carcinoma cells, suggesting that our data establish a fun-
damentally important original pathway to control cell architec-
ture (Fig. 10 J).
We find that depletion of MASTL renders cells nearly sta-
tionary with a very flat morphology devoid of obvious front-rear
polarity. MASTL overexpression also reduces directionality of
cell migration in MCF10A cells (Rogers et al., 2018), suggesting
that the levels of MASTL must be tightly regulated to maintain
optimal cell morphology for migration. The exact mechanism of
MASTL-induced cell motility and the role of its kinase activity in
regulating cell morphology has not been investigated in detail.
Contractility affects the dynamic properties of the actin cyto-
skeleton and its organization into lamellipodia and stress fibers
(Hirata et al., 2008; Hotulainen and Lappalainen, 2006;
Medeiros et al., 2006; Wilson et al., 2010). Therefore, our data
linking MASTL to contractility, through kinase-independent
activation of the MRTF–SRF pathway and positive regulation
of GEF-H1, is likely to be a central mechanism in MASTL regu-
lation of cell morphology. Previous work has indicated that ki-
nase activity is necessary for MASTL overexpression–induced
migration of MDA-MB-231 cells (Vera et al., 2015), whereas we
find that MASTL regulation of cell spreading and MRTF-A-SRF
signaling are independent of kinase function. Currently,
the reason for these somewhat discrepant findings is un-
clear. Recently, thrombocytopenia-associated mutations in
MASTL (including E167D) were shown to cause actin cytoskeletal
alterations in postmitotic platelets, suggesting that these are loss-
of-function mutations and indicating a clinically relevant role for
MASTL linked to the regulation of the cytoskeleton (Hurtado
et al., 2018). Accordingly, we find that the patient mutation
E167D renders MASTL inactive in augmenting SRF activity. In
breast cancer xenograft models, high MASTL levels have been
shown to positively correlate with tumor growth, invasion, and
metastasis (Álvarez-Fernández et al., 2018; Rogers et al., 2018;
Vera et al., 2015). We show here that silencing MASTL impairs
cell invasion in 3D, further supporting the notion of MASTL as
an important regulator of cell motility in different biological
contexts.
We found that MASTL was required for efficient serum-
induced nuclear translocation of MRTF-A and that this is inde-
pendent of MASTL kinase activity. MRTFs are predominantly
cytoplasmic in unstimulated cells, yet they continuously shuttle
through the nucleus. Signal-induced G-actin depletion (through
increased actin polymerization) decreases MRTF–actin interac-
tion in both the nucleus and cytoplasm and promotes MRTF
nuclear accumulation (Baarlink et al., 2013; Guettler et al., 2008;
Miralles et al., 2003; Vartiainen et al., 2007). We found no sig-
nificant difference in the F-actin/G-actin ratio of MASTL-
depleted cells. However, we found that MASTL associates with
MRTF-A and increases nuclear retention of MRTF-A. Thus, the
cell motility and contractility-promoting activities of MASTL
seem to be mediated through MRTF-A (and possibly through
other currently unknown mechanisms), but not through regu-
lation of G-actin levels.
We find that MASTL intersects with the Rho pathway
through regulating the expression of GEF-H1. Down-regulation
of GEF-H1 upon MASTL silencing correlates with increased cell
spreading and reduced stress-fiber formation, indicating a role
for GEF-H1 in the phenotype. However, unlike the other
MASTL-regulated genes/proteins studied here, GEF-H1 has not
been described as an SRF-target gene. Instead, GEF-H1 is a
known inducer of SRF (Itoh et al., 2014; Ly et al., 2013). This
implies that MASTL may regulate cell spreading also through
SRF-transcription–independent mechanisms that further en-
hance MASTL-mediated positive regulation of this signaling
pathway. GEF-H1 is a multifunctional protein implicated in
processes such as vesicle traffic (Pathak et al., 2012), cytokinesis
(Birkenfeld et al., 2008), endomitosis (Gao et al., 2012), G1/S
phase transition (Aijaz et al., 2005), cytokine production (Wang
et al., 2017), sensing of foreign RNA (Chiang et al., 2014), and
cellular adaptation to force (Guilluy et al., 2011). Importantly,
GEF-H1 is shown to be an oncogenic driver (Cullis et al., 2014).
Therefore, the link between MASTL and GEF-H1, revealed here,
most likely has a strong impact on a wide range of biological
processes.
MASTL overexpression in MCF10A cells increases aberrant
mitotic divisions resulting in increased micronuclei formation
(Rogers et al., 2018). Contractility is a key player in cell division.
It affects the assembly of the mitotic spindle architecture,
function, and orientation (Carreno et al., 2008; Chaigne et al.,
2013; Kunda et al., 2008; Théry et al., 2005). In the following
step, cytokinesis, the separation of the two cells relies on the
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actomyosin-derived forces generating the cleavage furrow
contractile zone (Mendes Pinto et al., 2013; Pollard, 2010). Thus
far, the majority of studies have focused on MASTL regulating
mitosis through the MASTL–ENSA–PP2A–B55 axis through
phosphorylation of ENSA (Vigneron et al., 2016). However, our
data showing kinase-activity independent MASTL regulation of
cell contractility and expression of cell adhesion/architecture
regulating proteins suggests that MASTL may contribute to
faithful cell division also through additional mechanisms.
Mechanistically, MASTL has been suggested to support on-
cogenicity by repression of the tumor suppressor activity of
PP2A-B55, increase in chromosome instability or deregulation of
the phosphoinositide 3-kinase-AKT-mammalian target of rapa-
mycin (PI3K–AKT–mTOR) pathway (Marzec and Burgess, 2018).
Our data suggest an additional mechanism where MASTL reg-
ulates actin morphology, adhesion, and migration of cells via
transcriptional control, which could have a highly important
role in cancer metastasis. In fact, drugs that would target
contractility (migrastatics) are suggested to work as anti-
cancer therapy for invasion and metastasis, the leading cause
of mortality in solid cancers (Gandalovičová et al., 2017).
Importantly, our transcriptome and proteome data provide a
resource unveiling several cancer-associated factors that are
down-regulated after MASTL depletion. This information
may lead to further breakthroughs into the exact role of
MASTL in cancer.
Materials and methods
Cell lines
MCF10A (human epithelial) cells were cultured in DMEM/Nu-
trient Mixture F-12 (Gibco) supplemented with 5% horse serum
(Gibco), 20 ng/ml EGF (Sigma-Aldrich), 0.5 µg/ml hydrocorti-
sone (Sigma-Aldrich), 100 ng/ml cholera toxin (Sigma), 10 µg/
ml insulin (Sigma-Aldrich), and 1% penicillin-streptomycin
(Sigma-Aldrich) in + 37°C, 5% CO2.
MDA-MB-231 (human triple-negative adenocarcinoma;
ATCC) cells were cultured in DMEM (Sigma-Aldrich) supple-
mented with 10% FBS (Sigma-Aldrich), 2 mM l-glutamine
(Sigma-Aldrich), and 1% MEM nonessential amino acid solu-
tion (Sigma-Aldrich) in 37°C 5% CO2.
MCF7 (human adenocarcinoma; ATCC) cells were cultured in
DMEM supplemented with 10% FBS (Sigma-Aldrich) and 2 mM
l-glutamine (Sigma-Aldrich) in 37°C 5% CO2.
All of the cell lines were mycoplasma negative.
Antibodies, siRNAs, primers, and DNA constructs
Table 1 lists the antibodies, siRNAs, primers, and DNA constructs
used in this study.
Transfections
Transfections of siRNAs were performed by using Lipofect-
amine RNAiMAX transfection reagent (Invitrogen) according to
manufacturer’s protocol.
Transfections of plasmid DNAs were performed by using
Lipofectamine 2000 Transfection Reagent (Invitrogen).
Adhesion assays
Adhesion assays were performed by using xCELLigence cell
analyzer RTCA (Roche). A 96-well E-Plate (Roche) was coated
with 5 µg/ml of collagen (PureCol; INAMED BioMaterials), fi-
bronectin (341631; Merck), or BSA (as a control) overnight at
4°C. Prior to the experiment, wells were blocked with 0.1% BSA
in PBS for 3 h at 37°C and washed with PBS. 50 µl of MDA-MB-
231 growth medium was added on each well, and background
signals were measured using the xCELLigence analyzer. Si-
lenced and/or transfected cells were detached by trypsinization,
followed by trypsin inactivation with 10% FBS. Cells were
centrifuged at 200 g to remove the serum, washed with serum-
free growth medium, recentrifuged, and resuspended in serum-
free medium. 2,000 cells diluted in 100 µl serum-free media
were added on each well, and cell index values indicating the
impedance between E-bottom electrodes were recorded imme-
diately in real time using the xCELLigence analyzer.
Cell spreading and immunostaining
siRNA-treated and/or transfected MDA-MB-231, MCF10A, or
MCF7 cells were plated on glass-bottom plates (MatTek) or
µ-slide eight-well chambered coverslips (ibidi), which had been
coated with 5 µg/ml collagen overnight at 4°C. Cells were al-
lowed to adhere in full growth media for 2 h in 37°C 5% CO2,
fixed with 4% PFA, washed with PBS, and permeabilized with
0.1% Triton-X in PBS. MDA-MB-231 andMCF7 cells were stained
with Phalloidin Atto-647N (1:200, 65906; Sigma-Aldrich) and
496-diamidino-2-phenylindole (DAPI, 1:10,000) in 1% BSA in PBS
for 45 min at RT and washed with PBS. MCF10A cells were first
stained with indicated primary antibodies in 1% BSA in PBS for
1 h at RT, washed with PBS, and incubated in Alexa Fluor sec-
ondary antibody (1:400), Phalloidin Atto-647N (1:200), and DAPI
(1:10,000) in 1% BSA in PBS for 45 min at RT. For Tpm4.2
staining, cells were fixed with 1% PFA with 20 mM Hepes for
Figure 10. Silencing of MASTL inhibits cancer cell invasion and regulates cell morphology in 3D. (A) Representative images of F-actin (Phalloidin-Atto)
staining in siControl and siMRTF-A–silenced (48 h) MCF10A cells plated on collagen for 2 h. Images were acquired on a 3i CSU-W1 spinning disk confocal.
(B) Quantification of cell area based on the F-actin staining of 45 cells (three independent experiments, unpaired t test). (C)Western blot analysis of MRTF-A,
GEF-H1, vinculin, paxillin, and GAPDH protein levels in siControl and siMRTF-A–silenced (48 h) MCF10A cells. (D–G) Inverted invasion assessment of siControl,
siMASTL, and siMRTF-A MDA-MB-231 cells. Schematic illustration of the invasion assay used and representative images for each condition after 96 h invasion
and staining with phalloidin-488; n = 3 biological replicates, with nine stacks/condition/replicate, mean ± SD, unpaired t test with Welch’s correction (D), along
with quantification (E). Representative high-magnification images (F) and quantification (G) of invading MDA-MB-231 cells assessed for their roundness (n = 3
biological replicates, with at least seven cells/condition/replicate, mean ± SD, unpaired t test with Welch’s correction;). (H and I) Representative high-
magnification images of MRTF-A staining and Hoechst (H) andMRTF-A nuclear/cytoplasmic ratio quantification (I) of invadingMDA-MB-231 cells. (J) Schematic
illustrating how MASTL regulates cell morphology, migration, and transcription of actin regulators by controlling the nuclear localization of MRTF-A and SRF
activity. Data in all graphs are from n = 3 biologically independent experiments (mean ± SD). See also Table S1.
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Table 1. Antibodies, siRNAs, primers, and DNA constructs used in this study
Reagent or resource Source Identifier
Antibodies
Rabbit anti-MASTL (1:1,000 for Western blot [WB]) Sigma-Aldrich Cat# HPA027175; RRID:
AB_1853591
Rabbit anti-MASTL (1:1,000 for WB) Abcam Cat# ab86387; RRID:AB_1925198
Mouse anti-α-tubulin (1:1,000 for WB, 1:100 for
immunofluorescence [IF])
Hybridoma bank 12g10anti-alpha-tubulin
Mouse anti-β1-integrin CD29 (1:1,000 for WB) BD Biosciences Cat# 610468; RRID:AB_397840
Mouse anti-GAPDH (1:20,000 for WB) HyTest Cat# 5G4MAB6C5
Mouse anti-paxillin (1:100 for IF, 1:1,000 for WB) BD Biosciences Cat# 612405, RRID:AB_647289
Rabbit anti-phospho-MLC 2 (Thr18/Ser19; 1:100 for IF) Cell Signaling Technology Cat# 3674, RRID:AB_2147464
Rabbit anti-MLC (phospho S20; 1:500 for WB) Abcam Cat# ab2480, RRID:AB_303094
Rabbit anti-MLC 2 (1:500 for WB) Cell Signaling Technology Cat# 3672, RRID:AB_10692513
Rabbit anti-GEF-H1 (1:1,000 for WB) Cell Signaling Technology Cat# 4076, RRID:AB_2060032
Rabbit anti-phospho-GEF-H1 (Ser886; 1:1,000 for WB) Cell Signaling Technology Cat# 14143, RRID:AB_2798402
Rabbit anti-tropomyosin 4.2 (Delta Tm 9d;
1:1,000 for WB, 1:100 for IF)
A kind gift from Prof. Peter Gunning (UNSW Sydney,
Sydney, Australia)
(Schevzov et al., 2011)
Mouse anti-nonmuscle myosin IIB (1:1,000 for WB) Abcam Cat# ab684, RRID:AB_305661
Mouse anti-vinculin (1:100 for IF, 1:1,000 for WB) Sigma-Aldrich Cat# V9131, RRID:AB_477629
Mouse anti-β-actin (clone AC-15; 1:1,000 for WB) Sigma-Aldrich Cat# A1978, RRID:AB_476692
Recombinant anti-β-catenin antibody (E247; 1:100 for IF) Abcam Cat# ab32572, RRID:AB_725966
Rabbit anti-E-cadherin (24E10; 1:100 for IF) Cell Signaling Technology Cat# 3195, RRID:AB_2291471
Rabbit anti-GEF-H1 (IF 1:100) Abcam Cat# ab155785, RRID:AB_2818944
Rabbit anti-phospho-paxillin (Tyr118; 1:1,000 for WB) Cell Signaling Technology Cat# 2541, RRID:AB_2174466
Mouse anti-MRTF-A (G-8; 1:200 for IF) Santa Cruz Biotechnology Cat# sc-390324
Donkey anti-mouse IgG (H+L) highly cross-adsorbed
secondary antibody, Alexa Fluor 568 (1:400 for IF)
Thermo Fisher Scientific Cat# A10037, RRID:AB_2534013
Donkey anti-mouse IgG (H+L) highly cross-adsorbed
secondary antibody, Alexa Fluor 488 (1:400 for IF)
Invitrogen Cat# A-21202
IRDye 680RD donkey anti-mouse IgG (1:5,000 for WB) LI-COR Biosciences Cat# 926-68072
Donkey anti-rabbit IgG (H+L) highly cross-adsorbed
secondary antibody, Alexa Fluor 488 (1:400 for IF)
Invitrogen Cat# A-21206
IRDye 800CW donkey anti-rabbit IgG (1:5,000 for WB) LI-COR Biosciences Cat# 926-32213
siRNAs and primers
AllStars negative control siRNA Qiagen 1027281
Hs_MASTL_6 FlexiTube siRNA (target sequence
59-ACGCCTTATTCTAGCAAATTA-39)
Qiagen SI02653014
Hs_MASTL_7 FlexiTube siRNA (target sequence
59-CAGGACAAGTGTTATCGCTTA-39)
Qiagen SI02653182
Hs_MASTL_11 FlexiTube siRNA (target sequence
59-CAGCCCTTAGATTCAGATAGA-39)
Qiagen SI04441066
Hs_MKL1_7 FlexiTube siRNA (target sequence
59-ATCACGTGTGATTGACATGTA-39)
Qiagen SI04172028
MRTF-A (sense strand 59-CCAUCAUUGUGGGCCAGGU-39) Sigma-Aldrich PDSIRNA5D
Hs_SRF_5 FlexiTube siRNA (target sequence
59-CAAGATGGAGTTCATCGACAA-39)
Qiagen SI02757622
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Table 1. Antibodies, siRNAs, primers, and DNA constructs used in this study (Continued)
Reagent or resource Source Identifier
RT-PCR primer for ARHGEF2 Universal Probe Library (Roche)
Forward: 59-TACCTGCGGCGAATTAAGAT-39
Reverse: 59-AAACAGCCCGACCTTCTCTC-39
Probe: 22
RT-PCR primer for GAPDH Universal Probe Library (Roche)
Forward: 59-GCCCAATACGACCAAATCC-39
Reverse: 59-AGCCACATCGCTCAGACA-39
Probe: 60
RT-PCR primer for MYH10 Universal Probe Library (Roche)
Forward: 59-GGAGGACACGCTGGACAC-39
Reverse: 59-TCTGCCACTTCTTGTTCACG-39
Probe: 3
RT-PCR primer for MASTL Universal Probe Library (Roche)
Forward: 59-GTCTGCAAACAATGTCTACTTGGTA-39
Reverse: 59-CTAGAGCCAGTGCTACTTCAGAAA-39
Probe: 76
RT-PCR primer for TPM4 Universal Probe Library (Roche)
Forward: 59-CGGTGAAACGCAAGATCC-39
Reverse: 59-GGCCACATCACCTTCAGC-39
Probe: 24
qPCR primer for TBP N/A N/A
Forward: 59-TGCACAGGAGCCAAGAGTGAA-39
Reverse: 59-CACATCACAGCTCCCCACCA-39
qPCR primer for SRF N/A N/A
Forward: 59-CAGATCGGTATGGTGGTCGG-39
Reverse: 59-GTCAGCGTGGACAGCTCATA-39
qPCR primer for FOS N/A N/A
Forward: 59-CTCTCTTACTACCACTCACCCGC-39
Reverse: 59-GGTCCGTGCAGAAGTCCTGCG-39
qPCR primer for VCL N/A N/A
Forward: 59-ACCAAGGCATAGAGGAAGCTTTA-39
Reverse: 59-GCTCTCTTCATGGCTTCAGTG-39
DNA constructs
pcDNA EGFP-C2 This paper N/A
pcDNA EGFP MASTL WT (siRNA resistant) This paper N/A
pcDNA EGFP MASTL G44S (siRNA resistant) This paper N/A
pcDNA EGFP MASTL E167D (siRNA resistant) This paper N/A
pIND20-MRTF-A-GFP Hinojosa et al., 2017 N/A
mEmerald-paxillin-22 A kind gift from Prof. Robert Grosse, Institute of
Experimental and Clinical Pharmacology and Toxicology,
University of Freiburg and CIBSS – Center for Integrative
Biological Signalling Studies, Freiburg, Germany
(plasmid 54219; Addgene; http://n2t.net/addgene:
54219; RRID:Addgene_54219)
(Paszek et al., 2012)
pcDNA3.1 EGFP ARHGEF2 A kind gift from Prof. Michael Sixt (The Institute of
Science and Technology Austria, Klosterneuburg,
Austria)
Kopf et al., 2019 Preprint
Taskinen et al. Journal of Cell Biology 16 of 23
MASTL: A transcriptional regulator of cytoskeleton https://doi.org/10.1083/jcb.201906204
D
ow
nloaded from
 https://rupress.org/jcb/article-pdf/219/6/e201906204/1042522/jcb_201906204.pdf by guest on 05 M
ay 2020
30 min at 37°C, permeabilized with ice-cold methanol for 5 min
at −20°C (which was slowly diluted out with PBS), and blocked
with 5% BSA in PBS for 1 h.
Stained cells were washed with PBS and imaged with con-
focal microscope 3i Spinning Disk, Hamamatsu ORCA-Flash4.0
v2 scientific complementary metal-oxide semiconductor (sCMOS)
camera (Hamamatsu Photonics), and Plan-Apochromat 63×,
1.4 NA oil objective, or with The Carl Zeiss LSM 880 Airyscan
and C Plan-Apochromat 63×/1.4 Oil differential interference
contrast UV-VIS-IR M27 (working distance [WD] 0.140 mm)
objective. Cell and focal adhesion areas were analyzed by using
ImageJ.
Focal adhesion dynamics
siControl and siMASTL MDA-MB-231 cells silenced for 48 h
expressing mEmerald-paxillin were plated on ibidi plate
(80826) coated with collagen (5 µg/ml) for 3 h before imaging.
Fluorescent cells were then imaged live using a Marianas spin-
ning disk imaging system with a Yokogawa CSU-W1 scanning
unit on an inverted Zeiss Axio Observer Z1 microscope con-
trolled by SlideBook 6 (Intelligent Imaging Innovations). Images
were acquired every minute using a Photometrics Evolve, 10-
MHz back-illuminated electron multiplying charge-coupled de-
vice (512 × 512 pixels) camera and 40× Zeiss long distance
C-Apochromat water objective (NA 1.1).
To quantify focal adhesion dynamics, videos were pre-
processed for brightness and background with ImageJ and fur-
ther processed using the Focal Adhesion Analysis Server (http://
faas.bme.unc.edu/; Berginski and Gomez, 2013) with the fol-
lowing analysis settings: minimum (min) adhesion size: 1; focal
adhesion (FA) phase length: 5; and focal adhesion alignment
index (FAAI): 3.
Western blot
Cells were washed with cold PBS, lysed with TX lysis buffer
(TXLB; 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.5% Triton-X,
0.5% glycerol, 1% SDS, Complete protease inhibitor [Sigma-
Aldrich], and phos-stop tablet [Sigma-Aldrich]), collected by
scraping, and transferred into an Eppendorf tube. Samples were
boiled for 5 min and sonicated. Protein concentrations were
measured using DC Protein assay (Bio-Rad) according to the
manufacturer’s protocol, and protein concentrations were nor-
malized by adding TXLB. SDS sample buffer was added on the
samples, and samples were boiled for 5 min. To separate the
proteins, samples with equal protein content were loaded on
precast Tris-Glycine-eXtendet SDS-PAGE gels with a 4–20%
gradient (Bio-Rad). The separated proteins were transferred
onto nitrocellulose membranes (Bio-Rad) using the Trans-Blot
Turbo Transfer System (Bio-Rad). Membranes were blocked
with 5% milk powder in Tris-buffered saline with 0.1% Tween
20 (TBST) for 1 h at RT. Membranes were incubated in primary
antibodies diluted in 5% milk in TBST at 4°C overnight. Mem-
branes were washed three times with TBST and incubated with
fluorophore-conjugated Odyssey secondary antibodies (LI-COR
Biosciences) for 1 h at RT. Membranes were washed again and
scanned with Odyssey infrared system (LI-COR Biosciences).
Band intensities were analyzed using ImageJ.
Immunoprecipitation
MCF7 cells stably expressing EGFP, EGFP MASTL WT, or EGFP
MASTL G44S were lysed in immunoprecipitation (IP)-lysis
buffer (0.5% Triton X-100, 10 mM Pipes, pH 6.8, 150 mM NaCl,
150 mM sucrose, 3 mM MgCl2, and complete protease and
phosphatase inhibitors [Mediq; Roche]), cleared by centrifuga-
tion (13,226 g, 10 min, 4°C), and incubated with GFP-trap beads
to pull down GFP proteins (gtak-20; Chromotek) for 1 h at 4°C.
Complexes bound to the beads were isolated using 1,000 g 3-min
centrifugation, washed three times with washing buffer (20 mM
Tris-HCl, pH 7.5) 150 mM NaCl, and 1% NP-40; 500 µl), and
eluted in sample buffer. Input and precipitate samples were
analyzed by Western blotting.
Integrin activity
As a positive control, one culture plate was activated by adding
0.5 mM MnCl2 to culture media for 1 h before collection. Cells
were harvested with HyQTase, which was inactivated by addi-
tion of full media and washed with serum-free media.
For the fibronectin-binding assay, cells were pelleted with
centrifugation at 200 g for 3 min and suspended into 100 µl of
serum-free media. For sample reactions, 1:50 diluted FN647
(0.6 mg/ml, Alexa Fluor 647–conjugated FN7-10, a kind gift from
Prof. R Fässler, Max Planck Institute of Biochemistry, Mar-
tinsried, Germany) was added. Positive control was supple-
mented with 0.5 mM MnCl2 and negative control with 5 mM
EDTA and preincubated for 10 min before addition of 1:50 di-
luted FN647 (0.6 mg/ml). All reactions were incubated 40min at
RT protected from light. Samples were washed two times with
cold Tyrode’s buffer (134 mM NaCl, 0.34 mM Na2HPO4, 2.9 mM
KCl, 12 mM NaHCO3, 20 mM Hepes, pH 7.0, 5 mM glucose, and
1 mM CaCl2), fixed with 4% PFA, and washed before analysis.
For antibody labeling, cells were washed with cold PBS, fixed
with 4% PFA for 15 min, and washed with Tyrode’s buffer. Cells
were then incubated with primary antibodies overnight at 4°C,
washed, and incubated with secondary antibodies for 1 h at 4°C.
After a final wash, cells were analyzed using a FACSCalibur (BD
Biosciences)machine and Flowing software. The fibronectin-binding
activation index was counted from the geometric mean fluores-
cence intensity (mGFI) using the formula mGFIsample − mGFIEDTA)/
mGFIsample and balanced to the signal of total integrin signal.
Cell cycle
Cells were detached with trypsin that was inactivated with full
media. Cells were pelleted with centrifugation at 200 g for
3 min, washed with PBS, and fixed with 70% −20°C EtOH. EtOH
was removed by centrifugation at 800 g for 4 min. Cells were
washed with PBS supplemented with 2% FBS and resuspended
into 200 µl of PBS. DNA was stained by adding 10 µl propidium
iodide (1 mg/ml; Sigma) and 2 µl RNaseA (10 mg/ml) and in-
cubated for 20 min. Cells were washed and analyzed using
FACSCalibur (BD Biosciences) and FlowJo (BD Biosciences) using
the Watson model.
Transcriptome analysis
Three biological replicates were prepared for control and
MASTL#6 silenced cells for 48 h and two biological replicates for
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24 h. RNA (500 ng) was amplified using Illumina TotalPrep RNA
Amplification Kit (Applied Biosystems) continued by in vitro
transcription reaction and biotinylation. The quality of the cRNA
was validated with electrophoresis (Bioanalyzer; Agilent). Each
cRNA (750 ng) was hybridized on HumanHT-12 v4 Expression
Bead Chip microarray (Sentrix; Illumina) at 58°C for 19 h ac-
cordingly to the Illumina Whole-Genome Gene Expression Di-
rect Hybridization Assay Guide protocol (part 11322355, rev. A).
Arrays were scanned with Illumina Bead Array Reader (factor =
1.0, voltage of the photomultiplier tube = 520, filter = 100%) and
results were processed with GenomeStudio v.2011.1; Gene Ex-
pression Module v.1.9.0.
The data were preprocessed using the Bioconductor lumi
package (Du et al., 2008). More specifically, gene expression
intensities were transformed using variance stabilizing trans-
formation and normalized using the quantile normalization
method (Lin et al., 2008). To reduce the number of false pos-
itives, probes that were determined as undetected (detection P
value > 0.01) in all the samples were filtered out from further
analysis. Out of the 47,321 probes on the array, 21,351 probes
remained after the filtering (∼45%). Differentially expressed genes
were identified between the siRNA and control samples at 24-h
and 48-h time points. Differential expression was determined
using a data-driven statistical procedure that determines the test
statistic by optimizing the reproducibility of the detections (Suomi
et al., 2017). Genes with FDR < 0.05 were defined as changed.
Proteome analysis
For quantitative mass spectrometry (MS) analysis, SILAC cells
were labeled by culturing them in DMEM without Arg/Lys
(A14431-01), 200 µM L-glutamine, 100 U/ml penicillin strepto-
mycin, 110 mg/l (1 mM) sodium pyruvate, and 10% 10 kD
dialyzed serum (F0392; Sigma-Aldrich). The media for light
labeling was supplemented with Arg 0 (84 mg/ml, A6969;
Sigma-Aldrich) and Lys 0 (146 mg/ml, L8662; Sigma-Aldrich),
and the media for heavy labeling was supplemented with Arg10
(CNLM-539-H; Cambridge Isotope Laboratories) and Lys8
(CNLM-291-H; Cambridge Isotope Laboratories). Incorporation
of the isotopes was confirmed after six passages. siControl and
siMASTL#6 silenced samples were prepared two times with
light- and heavy-labeled cells, obtaining four experimental
replicates. For each independent experiment, siControl and
siMASTL-silenced samples were mixed using a label-swap rep-
lication strategy (i.e., siControl-light mixed with siMASTL
silenced-heavy generates forward replicate 1; siMASTL silenced-
light with siControl-heavy generates reverse replicate 1, etc.).
48 h after silencing the cells were lysed with 4% SDS, 100 mM
DTT, and 100 mM Tris-HCl, pH 7.6, and boiled for 5 min at 95°C.
Samples were sonicated, centrifuged at 13,000 g for 10 min at
4°C, and transferred into a clean tube.
Proteomic sample preparation
Proteins obtained from total cell lysates were precipitated in two
steps using 24% and 10% solution of trichloroacetic acid. In both
steps, pellets were incubated at 4°C for 10min and centrifuged at
18,000 g for 5 min. Supernatants were carefully aspirated, and
pellets were washed with water until the supernatant reached
neutral pH. Pellets were reconstituted and digested, first using
endoproteinase Lys-C (ratio 1:33 enzyme/lysate; Alpha Labora-
tories) for 1 h at RT (24°C) and then trypsin (ratio 1:33 enzyme/
lysate; Promega) overnight at 35°C.
Offline HPLC fractionation
Protein digests were fractionated using high pH reverse-phase
chromatography. A C18 column (150 × 2.1 mm inside diameter
Kinetex EVO [5 µm, 100 Å]) was used with an HPLC system (LC
1260 Infinity II; Agilent). Modules were controlled by Chem-
station rev 01.07 SR2. Solvent A (98%water, 2% acetonitrile) and
solvent B (90% acetonitrile and 10% water) were adjusted to pH
10.0 using ammonium hydroxide. Samples were injected man-
ually through a Rheodyne valve onto the reverse phase–high
performance liquid chromatography (RP-HPLC) column equili-
brated with 1% solvent B and kept at this percentage for 3 min. A
two-step gradient was applied at a flow rate of 200 µl/min (from
1–25% B in 42min and then from 25–43% B in 8min) followed by
an 8-min washing step at 100% solvent B and an 8-min re-
equilibration step. Column eluate was monitored at 220 and 280
nm via a variable wavelength detector and collected using an
Agilent 1260 infinity fraction collector. Column eluate was col-
lected from 4 to 63 min and divided in 21 fractions.
Ultra-high performance liquid chromatography–MS/MS analysis
Fractionated tryptic digests were separated by nanoscale
C18 reverse-phase liquid chromatography using an EASY-nLC II
1200 (Thermo Fisher Scientific) coupled to a Q-Exactive HF
mass spectrometer (Thermo Fisher Scientific). Elution was
performed using a binary gradient with buffer A (2% acetoni-
trile) and B (80% acetonitrile), both containing 0.1% formic acid.
Samples were loaded into a 20 cm fused silica emitter (New
Objective) packed in-house with ReproSil-Pur C18-AQ, 1.9 µm
resin (Dr Maisch). Packed emitter was kept at 35°C by means of
a column oven (Sonation) integrated into the nanoelectrospray
ion source (Thermo Fisher Scientific).
Peptides were eluted at a flow rate of 300 nl/min using three
different gradients optimized for different set of fractions as
described previously (van der Reest et al., 2018). An Active
Background Ion Reduction Device was used to decrease air
contaminants signal level.
Data were acquired using Xcalibur software (Thermo Fisher
Scientific), and acquisition was performed in positive-ion mode
using data-dependent acquisition. A full scan (FT-MS) overmass
range of 375–1,400 m/z was acquired at 60,000 resolution at
200 m/z, with a target value of 3,000,000 ions for a maximum
injection time of 20 ms. Higher energy collisional dissociation
fragmentation was performed on the 15 most intense ions, for a
maximum injection time of 50 ms, or a target value of 50,000
ions. Multiply charged ions having intensity >12,000 counts
were selected through a 1.5-m/z window and fragmented using
normalized collision energy of 27. Former target ions selected for
MS/MS were dynamically excluded for 25 s.
Proteomics data analysis
The MS raw data were processed with MaxQuant software (Cox
and Mann, 2008) version 1.5.5.1 and searched with Andromeda
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search engine (Cox et al., 2011), querying UniProt (UniProt
Consortium, 2010; Homo sapiens [September 7, 2016; 92,939
entries]). For quantification, multiplicity was set to 2, and Arg0/
Arg10 and Lys0/Lys8 were used for ratio calculation of SILAC-
labeled peptides. First and main searches were performed with
precursor mass tolerances of 20 ppm and 4.5 ppm, respectively,
and MS/MS tolerance of 20 ppm. The minimum peptide length
was set to six amino acids, and specificity for trypsin cleavage
was required, allowing up to two missed cleavage sites. Methi-
onine oxidation and N-terminal acetylation were specified as
variable modifications and cysteine carbamidomethylation as
fixed modification. The peptide and protein FDR was set to 1%.
MaxQuant output was further processed and analyzed using
Perseus software version 1.5.5.4. Quantification was done using
the ProteinGroups.txt file, reverse and potential contaminant
flagged proteins were removed, and at least one uniquely as-
signed peptide and a minimum ratio count of 2 were required
for a protein to be quantified.
To identify regulated proteins, the two-sided significance B
algorithm (Cox and Mann, 2008) with a threshold value of 0.05
(Benjamini–Hochberg FDR used for truncation) was applied to
each replicate sample.
RT-PCR
RNA was isolated using the Nucleospin RNA kit (BioTop) fol-
lowed by DNase digestion with DNaseI Amplification Grade kit
(Invitrogen). RNA was processed to cDNA using high capacity
cDNA Reverse Transcription Kit (Thermo Fisher Scientific).
Micropatterns and stress fiber analysis
Coverglasses were coated with poly-L-lysine–grafted polyethy-
lene glycol to prevent protein binding. Micropatterns were
produced by exposing the coated glasses to UV light through a
micropatterned microplate to break poly-L-lysine–grafted pol-
yethylene glycol bonds and enable proteins to bind on the mi-
cropatterns (Azioune et al., 2009). The micropatterns were
coated with 5 µg/ml collagen overnight at 4°C and washed with
PBS, and cells were plated on micropatterned coverslips for 2 h.
Cells were fixed with 4% PFA, washed with PBS, permeabilized
with 0.2% Triton in PBS, stained with pMLC antibody overnight
at 4°C, and then washed with PBS and incubated with Alexa
Fluor 488 secondary antibody, Phalloidin Atto 647N (F-actin),
and DAPI (nucleus). Stress fibers were analyzed from images
stained with Phalloidin-Atto. The number of stress fibers was
analyzed by visual scoring and subdivided into three categories:
low, no obvious stress fibers; moderate, one to four stress fibers;
and high, five or more stress fibers. The width of the lamelli-
podium was measured from the widest point of the lamellipo-
dium and divided into three categories: narrow, 0–1.2 µm;
moderate, 1.2–2 µm; and wide, >2 µm.
Migration assay
siRNA-treated and/or transfected MDA-MB-231 cells were
plated on a 24-well plate in full growth media. The wells were
coated with 5 µg/ml collagen overnight at 4°C before the ex-
periment. Cells were imaged every 10min for 10 h using a Nikon
Eclipse Ti-E widefield microscope, Hamamatsu Orca C13440
Flash 4.0 ERG (b/w) sCMOS camera, and 20× Plan Apo lambda,
NA 0.75, WD 1,000 µm objective (for silenced cells) or 20× Ni-
kon CFI S Plan Fluor ELWD, NA 0.45, WD 8,200 µm (for silenced
and transfected cells). Cells were kept in full media and normal
growth conditions (37°C, 5% CO2) during imaging. To quantify
cell migration, cells were tracked with National Institutes of
Health (NIH) ImageJ Manual Tracking plug-in and analyzed
with NIH ImageJ Chemotaxis tool.
Inverted invasions
Inverted invasion assays were performed as previously de-
scribed (Jacquemet et al., 2016). Briefly, 200 µl collagen I (5 mg/
ml; #5074, PureCol EZ Gel; Advanced BioMatrix) spiked with
fibronectin (25 µg/ml; #341631; Millipore) was allowed to po-
lymerize inside transwell inserts (8 µm ThinCert; Greiner
Bio-One) for 1 h at 37°C. MDA-MB-231 cells were silenced with
siControl, siMASTL #6, siMASTL #11, siMRTF-A #1, and siMRTF-
A #2 in serum-free media overnight, as above. The transwells
were then inverted, and 105 cells/insert were seeded onto the
opposite face of the filter and allowed to incubate upside down
for a further 3 h at 37°C. Inserts were then washed with PBS
before placement in 1 ml serum-free medium/24-well well. To
establish a chemotactic gradient, 300 µl media supplemented
with 10% FBS was placed in the top of the transwell insert. After
96 h, invading cells were fixed in 4% PFA with 0.5% (vol/vol)
Triton-X-100 at RT for 2 h. Invasions were then stained over-
night at 4°C using Alexa Fluor 488 phalloidin (1:50, A12379; Life
Technologies). These were then washed three times using PBS
and imaged on a confocal microscope (LSM880; Zeiss), capturing
serial optical sections every 15 µm with a 40× objective (NA 1.2
immersion, Plan-Apochromat). Invasion was quantified with
ImageJ (NIH) using the area calculator function, comparing the
area covered by cells that had invaded ≥45 µm, as a percentage of
the area of all cells within the matrix.
For immunofluorescence staining, fixed invasions were
subsequently removed from the transwell inserts and cut in half
before blocking with 5% BSA and incubation with MRTF-A
primary antibody overnight at 4°C. These were then washed
with PBS and incubated for 1 h at RT with anti-mouse-568
and Hoechst 33342 (5 µg/ml, H3570; Invitrogen). After further
washing, samples were imaged on a confocal microscope
(LSM880; Zeiss), capturing serial optical sections every 1–2 µm
with a 40× objective (NA 1.2 immersion, Plan-Apochromat).
Collagen within the inverted invasion matrices was visualized
by reflectance confocal microscopy using the 633-nm laser line.
Cell shape was then assessed in ImageJ (NIH) with the shape
descriptor measurement, roundness. The MRTF-A nuclear-to-
cytoplasmic ratio in invasive MDA-MB-231 cells in 3D collagen
matrices was assessed by measuring the integrated density of
MRTF-A staining in regions masked with Hoechst 33342 and
phalloidin-488 and then calculating the ratio of staining inten-
sity between these two cellular compartments.
FLIP
MCF7 cells were silenced overnight with siControl and siMASTL
#11, as above, before transfection with pInd20-MTRF-A-EGFP
overnight in serum-freemedia, as above, in the presence of 1 µg/ml
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doxycycline. FLIP experiments were conducted on a confocal
microscope (LSM880; Zeiss) with a 40× objective (NA 1.2 im-
mersion, Plan-Apochromat) using cells that had been incubated
with Sir-DNA (1:2,000, CY-SC007; Cytoskeleton) for 1 h.
Bleaching was then performed after addition of 10% FBS for
10 min using the 488-nm laser line in a 75 × 125 µm region of the
cytoplasm and surroundings, excluding the nucleus, every 20 s
for at least 12 min, acquiring an image of the cell after each
bleach. A ratio for MRTF-A localization was measured by first
making a nuclear mask using the Sir-DNA channel and then
measuring the integrated density of the fluorescent MRTF-A
signal in the nuclear region of interest at each time point using
ImageJ.
Orientation analysis
β-Catenin junction orientation analysis was performed on con-
focal images using the OrientationJ plugin for ImageJ (NIH;
https://www.ncbi.nlm.nih.gov/pubmed/21744269). This was
done by computing the structure tensors within each input
image using a cubic spline interpolation, which assesses the local
orientation and isotropic properties of the pixels. The local
predominant orientation of these tensors (measured in degrees)
was then peak aligned and the frequency of junction alignment
calculated across the 30° spanning the peak alignment.
F-actin/G-actin fractionation
MCF10A cells were treated with siRNAs for 48 h or with 0.1 µM
jasplakinolide (J4580; Sigma-Aldrich) or DMSO (control) for
30 min. Cells were washed twice with PBS on ice and lysed with
750 µl actin lysis buffer (0.5% Triton-X, 20 mM Hepes, pH 7.9,
50 mM NaCl, 1 mM EDTA, and EDTA-free protease inhibitor
cocktail tablet [Roche] in PBS) on ice for 15 min (Grosse et al.,
2003; Posern et al., 2002). Cells were collected by scraping and
fractionated by ultracentrifugation at 100,000 g for 1 h at 4°C.
The supernatant (G-actin fraction) was collected andmixed with
SDS-PAGE loading buffer, whereas the pellet (F-actin fraction)
was resuspended with 750 µl actin lysis buffer mixed with SDS-
PAGE loading buffer. Equal amounts of fractions were separated
on SDS-PAGE followed by immunoblotting with indicated
antibodies.
qPCR
RNA was isolated from siRNA treated (72 h) MCF10A cells by
using Trizol reagent (Peqlab) according to the manufacturer’s
instructions followed by reverse transcription done by using
RevertAid Reverse transcription (Thermo Fisher Scientific).
Obtained cDNA was quantified using SYBR green Master Mix
(Bio-Rad) with real-time qPCR on a Real Time Quantitative
Thermal Cycle (Bio-Rad).
SRF luciferase assay
To assess SRF activity, we used a MCF10A cell line stably ex-
pressing MRTF-SRF–specific promoter 3Da.luc linked to GFP
(Hinojosa et al., 2017). These cells were transfected with control,
MASTL#6, and SRF siRNAs. After 48 h, cells were serum de-
prived for 24 h followed by serum stimulation with 0% (control)
or 20% horse serum for 7 h. The amount of firefly was measured
luminometrically for each condition. Alternatively, MRTF/SRF
activity was determined as described previously (Kreßner et al.,
2013) using p3DA.luc (firefly luciferase) and pRL-TK (Renilla
luciferase control) reporter plasmids transiently transfected to
MCF7 cells with EGFP or EGFP-MASTL plasmids, as indicated.
After transfection, cells were maintained in 0.5% FBS for 17 h
before analysis and stimulated with 20% FBS for 7 h. The amount
of firefly relative to Renilla was measured luminometrically for
each condition.
MRTF-A translocation assay
MCF10A cells stably expressing pIND20-MRTF-A-GFP were
transiently transfected with siMASTL#6 or control siRNAs. Af-
ter 48 h silencing and 24 h before live-cell imaging, cells were
simultaneously serum-deprived and stimulated with 333 ng/ml
doxycycline to induce MRTF-A-GFP expression. Serum stimu-
lation was performed by adding 20% serum to the cells under a
confocal microscope LSM 800 (Zeiss), and cells were imaged in a
CO2-humidified incubation chamber every 10 s to studyMRTF-A
nuclear translocation. Alternatively, MCF10A cells were plated
on glass-bottom plates (MatTek) for 24 h and transfected with
EGFP or EGFP-MASTL plasmids in serum-freemedium. After 24 h,
20% horse serumwas added, and cells were fixed with 4% PFA 0,
2, or 5 min after adding serum. Next, the cells were per-
meabilized with 0.1% Triton in PBS and stained with MRTF-A
antibody overnight at 4°C, washed with PBS, and incubated with
Alexa Fluor 555 secondary antibody, Phalloidin-Atto 647N
(F-actin), and DAPI (nucleus). The samples were imaged with
the Marianas spinning disk imaging system with a Yokogawa
CSU-W1 scanning unit on an inverted Zeiss Axio Observer Z1
microscope controlled by SlideBook 6 (Intelligent Imaging In-
novations) using an Orca Flash 4 sCMOS camera (2,048 × 2,048;
Hamamatsu Photonics) and 20× (NA 0.8 air, Plan Apo, DIC;
Zeiss) objective.
Quantification and statistical analysis
Detailed statistical analyses used for individual experiments are
listed in Table S1. GraphPad Prism version 6.05 for Windows
(GraphPad Software) was used to determine the P values and
perform statistical analysis. An unpaired t test with Gaussian
distribution was used, andmean with SD values are presented in
all figures, except for stress fiber quantification (Fig. 5, B and C),
where the Fisher’s exact test was applied; and accumulative
distance for migration (Fig. 6 C), where Welch’s correction was
performed. The result was defined to be significant if the P value
was < 0.05. The exact P values < 0.05 are marked in each figure.
Higher P values are marked not significant in the figures, and
the exact P values are provided in Table S1.
Data and software availability
The transcriptome data are available in the Gene Expression
Omnibus (GEO), accession no. GSE131833. The mass spectrom-
etry proteomics data have been deposited to the Proteo-
meXchange Consortium via the PRIDE (Perez-Riverol et al.,
2019) partner repository with the dataset identifier PXD013757.
The proteome data are available in PRIDE. The raw files and
the MaxQuant search results files have been deposited as partial
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submission to the ProteomeXchange Consortium via the PRIDE
partner repository (Perez-Riverol et al., 2019) with the dataset
identifier PXD013757.
Online supplemental material
Fig. S1 shows that MASTL depletion promotes MDA-MB-231 cell
spreading and attachment on fibronectin and collagen (related to
Figs. 1 and 2). Fig. S2 shows MASTL protein levels in one normal
breast and two breast cancer cell lines and that MASTL silencing
promotes cell spreading in MCF7 breast cancer cells and MASTL
silencing does not affect focal adhesion size, integrin activity, or
cell cycle in MDA-MB-231 cells (related to Fig. 2). Fig. S3 con-
firms MASTL silencing with Western blot and RT-PCR (for
transcriptome and proteome experiments related to Fig. 4). Fig.
S4 contains Western blot and/or immunofluorescence anlysi of
GEF-H1 and Tpm4.2 expression in MCF10A and MDA-MB-231
cells afterMASTL silencing with an additoinal siRNA.Moreover,
transient GEF-H1 expression after MASTL silencing does not
rescue cell migration (related to Fig. 5). Fig. S5 shows that
MASTL depletion reduces vinculin-positive focal adhesion size,
vinculin is present in cell–cell junctions, overexpression of
MASTL-E167D cannot induce SRF activity, and that MASTL si-
lencing does not affect the F-actin/G-actin ratio (related to
Fig. 8). Table S1 contains the statistics related to all figures. Table
S2 shows the Illumina transcriptome data of MASTL-silenced
cells (related to Fig. 3). Table S3 contains the SILAC proteome
data of MASTL-silenced cells (related to Fig. 3). Video 1 is a
bright-field time-lapse movie of siControl MDA-MB-231 cells
migrating on collagen (related to Fig. 7). Video 2 is a bright-field
time-lapse movie of siMASTL MDA-MB-231 cells migrating on
collagen (related to Fig. 7). Video 3 is a time-lapse movie of focal
adhesion kinetics in mEmerald-paxillin–labeled siControl and
siMASTL MDA-MB-231 cells.
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Supplemental material
Figure S1. MASTL inhibits cell spreading and attachment (related to Figure 1). (A)Western blot analysis of MASTL and GAPDH afterMASTL silencing (48 h)
with siRNAs #6 and #7 in MDA-MB-231 cells. (B–D) Quantification of cell attachment (normalized cell index, impedance) at the 2-h time point measured with
xCELLigence after plating of single MDA-MB-231 cells (siControl or siMASTL, 48 h) on fibronectin silenced with siMASTL#6 (n = 4 biologically independent
experiments, mean ± SD, unpaired t test; B), fibronectin silenced with siMASTL#7 (n = 2 biologically independent experiments; C), or collagen silenced with
siMASTL#7 (n = 2 biologically independent experiments; D). (E) Western blot analysis of MASTL and tubulin in MDA-MB-231 cells after 24-h overexpression of
EGFP-control or EGFP-MASTL WT. (F) Quantification of cell attachment at the 2-h time point (from Fig. 1 I curves) of siControl (48 h), siMASTL (48 h), or EGFP-
MASTL WT–reexpressing (24 h silencing + 24 h expression of siRNA-resistant MASTL) MDA-MB-231 cells on collagen. See also Table S1.
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Figure S2. MASTL regulates cell spreading independently of focal adhesion size, integrin activity or cell cycle (related to Fig. 2). (A) Western blot
analysis of MASTL, tubulin and β-actin in MCF10A, MCF7 and MDA-MB-231 cells. (B) Representative images of F-actin (Phalloidin-Atto) and DAPI staining in
control (siControl) or MASTL-silenced (siMASTL; 48 h silencing) MCF7 cells plated on collagen for 2 h. Images were acquired on a 3i CSU-W1 spinning disk
confocal. (C) Quantification of cell area based on F-actin staining of 45 cells (3 independent experiments) from B. (D and E) Quantification of the flow cy-
tometry of total β1-integrin (P5D2; D) or active β1-integrin (12G10; E) in siControl and siMASTL (48 h) cells (n = 3 biologically independent experiments, mean ±
SD, unpaired t test, MDA-MB-231). (F and G) Level of active β1 integrin (12G10) relative to total β1 integrin (K20) after MASTL#6 silencing (F; n = 6 independent
experiments, mean ± SD, t test, MDA-MB-231) or after MASTL#7 silencing (G; n = 3 independent experiments, mean ± SD, unpaired t test). (H) Western blot
analysis of MASTL and GAPDH in siControl and siMASTL (24, 48, or 72 h) MDA-MB-231 cells at different time points. (I) Quantification of the flow cytometry
data (Fig. 2 I). Proportion of MDA-MB-231 cells in the G2 phase of the cell cycle (Watsonmodel) after silencing of MASTL for 24, 48, and 72 h (n = 3 independent
experiments [1 × #6, 2 × #7], mean ± SD, unpaired t test). See also Table S1.
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Figure S3. MASTL silencing confirmed with Western blot and RT-PCR (for experiments related to Fig. 4). (A) Western blot analysis of MASTL and
GAPDH 24 h and 48 h after silencing of MASTL#6 in samples used for the transcriptional analysis, MDA-MB-231 cells. (B) RT-PCR of MASTL relative to GAPDH
24 h and 48 h after silencing of MASTL#6 in samples used for the transcriptional analysis (n = 3 independent experiments, mean ± SD, unpaired t test, MDA-
MB-231 cells). (C) Western blot analysis of MASTL and GAPDH 48 h after silencing of MASTL#6 in MDA-MB-231–labeled cells used for the total proteome
analysis (MDA-MB-231 cells). H, heavy isotopes (Arg10, Lys8); L, light isotopes (Arg0, Lys0). See also Table S1.
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Figure S4. MASTL regulates GEF-H1, Tpm4.2, and NM-2B levels and GEFH1 rescues cell spreading, but not cell migration, in MASTL-silenced cells
(related to Figure 5). (A) Western blot analysis of GEF-H1, Tpm4.2, and MASTL protein levels in siControl, siMASTL#6, and siMASTL#7 MDA-MB-231 cells.
(B) Representative GEF-H1 and tubulin staining in siControl, siMASTL#6, and siMASTL#11 MDA-MB-231 cells. Images were acquired on a 3i CSU-W1 spinning
disk confocal. (C) Western blot analysis of GEF-H1 and MASTL protein levels in siControl, siMASTL#6, and siMASTL#7 MCF10A cells. (D) Representative
Tpm4.2 staining in siControl, siMASTL#6, and siMASTL#11 MCF10A cells. (E) Representative F-actin (Phalloidin-Atto) and DAPI staining in siControl and
siMASTL#11 MDA-MB-231 cells transfected with EGFP or EGFP-GEF-H1 for 24 h and plated on collagen for 2 h. Images were acquired on a 3i CSU-W1 spinning
disk confocal. (F) Migration track length of siControl and siMASTL#11 MDA-MB-231 cells transfected with EGFP or EGFP-GEF-H1 for 24 h. Cells were imaged
every 10 min for 600 min in total (n = 3 biologically independent experiments, mean ± SD, unpaired t test). See also Table S1.
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Figure S5. MASTL regulation of vinculin-positive focal adhesions and SRF activity (related to Fig. 8). (A) Quantification of paxillin levels after MASTL
silencing. Protein levels are normalized by GAPDH (n = 3 biologically independent experiments, mean ± SD, unpaired t test). (B) Representative images of
F-actin (Phalloidin-Atto), vinculin, and DAPI staining in siControl and siMASTL (48 h silencing) MCF10A cells plated on collagen for 2 h, and quantification of
focal adhesion size based on vinculin staining (three independent experiments). Images were acquired on a 3i CSU-W1 spinning disk confocal. (C) Repre-
sentative staining of vinculin and E-cadherin in confluent siControl, siMASTL#6 and siMASTL#11 MCF10A cells. Images were acquired on a 3i CSU-W1 spinning
disk confocal. (D) Relative SRF luciferase activity. MCF7 cells expressed EGFP control and EGFP-MASTL E167D together with the SRF reporter 3D.Aluc and
RLTK Renilla luciferase transfection control under serum-starved conditions and after stimulation with 20% serum. (E)Western blot of β-actin in F- and G-actin
fractions of MCF10A cells treated with DMSO or jasplakinolide (Jasp.; 0.1 µM, 30 min) or silenced with siControl, siMASTL#6, or siMASTL#7 (48 h).
(F) Quantification of F-actin protein levels relative to G-actin in MCF10A cells after treatments from B (n = 3 biologically independent experiments, mean ± SD,
unpaired t test). See also Table S1.
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Video 1. siControl MDA-MB-231 cells migrating on collagen. Bright-field time-lapse image sequences taken at 10-min intervals. Video corresponds to Fig. 7
A. Frame rate of the video is 7 frames per second.
Video 2. siMASTLMDA-MB-231 cells migrating on collagen. Bright-field time-lapse image sequences taken at 10-min intervals. Video corresponds to Fig. 7
A. Frame rate of the video is 7 frames per second.
Video 3. Focal adhesion kinetics in mEmerald-paxillin-labelled siControl and siMASTL MDA-MB-231 cells. Time-lapse image sequences taken at 1-min
intervals. Video corresponds to Fig. 7 D. Frame rate of the video is 7 frames per second.
Provided online are three tables. Table S1 contains the statistics related to all figures in an Excel file. Table S2 shows the Illumina
transcriptome data of MASTL-silenced cells (related to Fig. 3) in an Excel file. Table S3 contains the SILAC proteome data of MASTL-
silenced cells (related to Fig. 3) in an Excel file.
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